Craft

Elicio Therapeutics

Total Funding

$150.3 M

Elicio Therapeutics Summary

Company summary

Overview
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. It engineers Amphiphiles that target and concentrate different immunogens in the lymph nodes, resulting in tumor or pathogen targeted immunity, including potent T cell and humoral responses.
Type
Private
Status
Active
Founded
2011
HQ
Cambridge, MA, US | view all locations
Website
https://elicio.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    One Kendall Square, Building 1400 West, Suite 14303

Footer menu